Endologix selects John McDermott as chairman of the board of directors

107

Endologix has announced the appointment of John McDermott, Endologix’s president and CEO, to the additional position of chairman of the board of directors. The transition will be effective on 24 May 2012, date of the company’s annual shareholder’s meeting.

Franklin D Brown announced his decision to retire as chairman of the board at the end of his current term, after a highly successful and distinguished 15-year career with the company. He served in several executive leadership positions, including CEO from 1998 to 2003 and the most recent, chairman of the board from 1998 to 2012.
 

“I have been privileged to be involved in the success of Endologix and the timing of this announcement is consistent with my long-term plans for retirement. The company has achieved strong growth and substantially enhanced its new product pipeline under the leadership of John McDermott and the current board of directors, giving me high confidence that the company remains in good hands,” said Brown.


“On behalf of the company and the board of directors, I would like to thank Frank for his long service to the company, both as CEO and a member of the board. We would not be in the strong position we are today without his leadership and strategic guidance,” said McDermott.